LONDON, ONTARIO – February 19, 2013 – Sernova Corp.
(“Sernova” or the “Company”) (TSX VENTURE: SVA) today announces that further to its news release dated January 21, 2013, it has now closed its non-brokered private placement consisting of 10,000,000 units (the “Units”) at a price of $0.20 per Unit for gross proceeds of $2,000,000 (the “Offering”).
Net proceeds from the offering will be utilized in the advancement of Sernova’s clinical development program of its Cell Pouch™ for the treatment of diabetes, new product initiatives and general corporate purposes.
Read more